Gynaecological Oncology

Introduction to Gynaecological Oncology

The Gynaecologic Oncology team is a division of the Department of Obstetrics & Gynaecology, the University of Hong Kong, Queen Mary Hospital. For over forty years, we have been providing specialized care for women with gynaecologic cancer. We are a tertiary referral centre for both common and rare gynaecological malignancies, with patients referred from both private and government hospitals in Hong Kong and Macau. As a leading hospital we conduct different kinds of cancer surgery, including laparoscopic and robotic-assisted operations. Besides, our unit also offers chemotherapy, hormonal and targeted therapy. Our team works closely with the Department of Clinical Oncology and Palliative team which provide radiotherapy and palliative care. Our services are supported by other departments such as the Departments of Pathology, Radiology, Surgery and Medicine, and we receive support from other allied teams including physiotherapists, occupational therapists, dietitians, social workers and psychologists.

Our division is recognized by the Hong Kong College of Obstetricians & Gynaecologists, the Royal College of Obstetricians & Gynaecologists, UK for the training of gynaecological oncologists. A special programme is offered for overseas fellows or scholars. The division also provides training in gynaecological oncology to basic and advanced trainees in Obstetrics & Gynaecology in Hong Kong and abroad. We contribute to undergraduate teaching where gynaecologic oncology is in the core curriculum of Obstetrics & Gynaecology. Our team is eager on updating our knowledge and techniques and we invite different overseas experts to visit our centre for exchange of ideas.

Our division is active in both basic and clinical research. There are laboratory facilities and expertise in immunoassays, biomolecular studies on DNA, RNA and protein. We have multi-centre studies on cervical cancer and gestational trophoblastic disease follow-up programme and clinical trials in collaboration with the other departments in the University of Hong Kong, including Department of Pathology, Department of Clinical Oncology, Department of Psychiatry, Department of Diagnostic Radiology and allied health services including Physiotherapy.

Staff (Clinical/Nursing/Laboratory)
  • Dr. Karen K.L. CHAN, Associate Professor, (Division Head, Accredited gynaecological oncologist)
  • Prof. Hextan Y.S. NGAN, Chair Professor, (Accredited gynaecological oncologist)
  • Dr. S.F. NGU, Associate Professor (Accredited gynaecological oncologist)
  • Dr. K.Y. TSE, Associate Professor, (Accredited gynaecological oncologist)
  • Dr. Mandy M.Y. CHU, Consultant, (Accredited gynaecological oncologist)
  • Dr. S.T. Gladys KWOK, Associate Consultant
Staff in rotating positions:

1-2 basic / higher specialist trainee(s) / specialist(s)
2 house officers
1 overseas fellow

  • Ms Polly P.Y. HO, Gynaecological Oncology Ward Manager
  • Ms L.H. CHAN, Nursing Officer, Nurse Specialist in Stoma Care
  • Ms H.Y. CHIU, Registered Nurse, APN Palliative Medical Unit
Laboratory research team:
  • Dr. Stephanie S. LIU, Research Officer
  • Dr. Michelle K.Y. SIU, Research Officer
  • Dr. W.S. CHAN, Postdoctoral Fellow
  • Dr. Mingo M.H. YUNG, Postdoctoral Fellow
Clinical research team:
  • Ms L.S.K. Lau, Research Coordinator
  • Ms Iris W.K. TANG, Research Assistant
  • Ms Katherine X. ZHONG, Research Assistant

Clinical Services
Clinic Time
Colposcopy Clinic Monday pm, Tuesday am, Thurs pm, Fri pm
Vulval Clinic Friday pm (1 session / month )
Chemotherapy Clinic Thursday am and pm
Trophoblastic Clinic Wednesday pm
Cancer Follow-up Clinic Wednesday pm
Palliative Clinic Thursday am
Pre-admission Clinic Thursday am

Operation Sessions

Elective Operation Tuesday a.m. & p.m.
Elective Operation Friday a.m. & p.m.
Emergency 24 hours

Teaching sessions
Investigation Teaching Sessions
Grand round 1 per week
Discussion of new cases 1 per week
Morbidity and mortality meeting 1 per week
Pre-operative round 1 per week
Chemotherapy round 1 per week
Radiology meeting 1 per week
Tumour board meeting 1 per week
Colposcopy - cytology - histology review 1 per 3 months
Palliative team meeting 1 per month
Research meeting 2 per month
Journal club 1 per 1-2 months
Statistics and topic discussion 1 per 3 months

Current Clinical Trials
  1. ALARICE study

    Avelumab With Axitinib in Persistent or Recurrent Cervical Cancer After Platinum-based Chemotherapy - a Proof-of-concept Study

  2. NEOPRIMA study

    Niraparib Maintenance in Patients With Advanced Ovarian Cancer at Neoadjuvant Setting - a Phase 2, Single-arm Trial

  3. DUO-E study

    A Randomised, Multicentre, Double-blind, Placebo-controlled, Phase III Study of First-line Carboplatin and Paclitaxel in Combination With Durvalumab, Followed by Maintenance

    Durvalumab With or Without Olaparib in Patients With Newly Diagnosed Advanced or Recurrent Endometrial Cancer (DUO-E)

  4. NEOPRIMA study

    Phase II Study of Weekly Paclitaxel and Cisplatin in FIGO IB2 and IIA2 Cervical Cancer Followed by Radical Hysterectomy